Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis

European Respiratory Journal

Volumn 39, Issue 1, 2012, Pages 133-140

  Mubarak, K K ^a   Montes Worboys, A ^a   Regev, D ^a   Nasreen, N ^a,b   Mohammed, K A ^a,b   Faruqi, I ^a   Hensel, E ^a   Baz, M A ^a   Akindipe, O A ^a   Fernandez Bussy, S ^a   Nathan, S D ^c   Antony, V B ^d  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c INOVA HEART AND VASCULAR INSTITUTE   (United States)

^d Allergy and Critical Care Medicine   (United States)

Author keywords

Cell trafficking; Epithelial mesenchymal transition; Idiopathic pulmonary fibrosis; Mesothelial mesenchymal transition; Pathogenesis; Pleural mesothelial cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALRETININ; GREEN FLUORESCENT PROTEIN; MESOTHELIN; NANOPARTICLE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASHCROFT SCORE; CELL COUNT; CELL LABELING; CELL MIGRATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CYSTIC FIBROSIS; EXPLANT; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG LAVAGE; LUNG PARENCHYMA; MESOTHELIUM CELL; MOUSE; NONHUMAN; PLEURA CAVITY; PLEURAL MESOTHELIAL CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; ANIMALS; CALCIUM-BINDING PROTEIN, VITAMIN D-DEPENDENT; CELL NUCLEUS; CHILD; CYSTIC FIBROSIS; EPITHELIAL-MESENCHYMAL TRANSITION; EPITHELIUM; FEMALE; GPI-LINKED PROTEINS; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; IMMUNOHISTOCHEMISTRY; LUNG; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MYOFIBROBLASTS; PLEURA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84855375381     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00141010     Document Type: Article

References (45)

1. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003; 112: 1776-1784. (Pubitemid 38063698)
2. Neilson EG, Plieth D, Venkov C. Epithelial-mesenchymal transitions and the intersecting cell fate of fibroblasts and metastatic cancer cells. Trans Am Clin Climatol Assoc 2003; 114: 87-100.
3. Noble PW. Idiopathic pulmonary fibrosis. New insights into classification and pathogenesis usher in a new era therapeutic approaches. Am J Respir Cell Mol Biol 2003; 29: Suppl. 3, S27-S31. (Pubitemid 37070304)
4. Abe R, Donnelly SC, Peng T, et al. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001; 166: 7556-7562. (Pubitemid 32525636)
5. Iwano M, Plieth D, Danoff TM, et al. Evidence that fibroblasts derive from epithelium during tissue fibrosis. J Clin Invest 2002; 110: 341-350. (Pubitemid 34847966)
6. Nasreen N, Mohammed KA, Mubarak KK, et al. Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-β1 in vitro. Am J Physiol Lung Cell Mol Physiol 2009; 297: L115-L124.
7. Strutz F, Zeisberg M, Ziyadeh FN, et al. Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int 2002; 61: 1714-1728. (Pubitemid 34437925)
8. Pochetuhen K, Luzina IG, Lockatell V, et al. Complex regulation of pulmonary inflammation and fibrosis by CCL18. Am J Pathol 2007; 171: 428-437. (Pubitemid 47344676)
9. Broekelmann TJ, Limper AH, Colby TV, et al. Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc Natl Acad Sci USA 1991; 88: 6642-6646. (Pubitemid 21915005)
10. Willis BC, du Bois RM, Borok Z. Epithelial origin of myofibroblasts during fibrosis in the lung. Proc Am Thorac Soc 2006; 3: 377-382. (Pubitemid 43845416)
11. Zeisberg M, Kalluri R. The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med 2004; 82: 175-181. (Pubitemid 38392167)
12. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247-2250. (Pubitemid 30081976)
13. Verrecchia F, Mauviel A. Transforming growth factor-β and fibrosis. World J Gastroenterol 2007; 13: 3056-3062.
14. Quintana HK, Cannet C, Schaeublin E, et al. Identification with MRI of the pleura as a major site of the acute inflammatory effects induced by ovalbumin and endotoxin challenge in the airways of the rat. Am J Physiol Lung Cell Mol Physiol 2006; 291: L651-L657. (Pubitemid 44498476)
15. Song Y, Li X, Du X. Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma. Eur Respir J 2009; 34: 559-567.
16. Antony VB. Immunological mechanisms in pleural disease. Eur Respir J 2003; 21: 539-544. (Pubitemid 36336217)
17. Quintana HK, Cannet C, Schaeublin E, et al. Identification with MRI of the pleura as a major site of the acute inflammatory effects induced by ovalbumin and endotoxin challenge in the airways of the rat. Am J Physiol Lung Cell Mol Physiol 2006; 291: L651-L657. (Pubitemid 44498476)
18. Cool CD, Groshong SD, Rai PR, et al. Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum. Am J Respir Crit Care Med 2006; 174: 654-658. (Pubitemid 44395332)
19. Decologne N, Wettstein G, Kolb M, et al. Bleomycin induces pleural and subpleural fibrosis in the presence of carbon particles. Eur Respir J 2010; 35: 176-185.
20. Baumgartner KB, Samet JM, Stidley CA, et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997; 155: 242-248. (Pubitemid 27053171)
21. Ashcroft T, Simpson JM, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 1988; 41: 467-470. (Pubitemid 18098428)
22. Mohammed KA, Nasreen N, Ward MJ, et al. Helper T cell type 1 and 2 cytokines regulate C-C chemokine expression in mouse pleural mesothelial cells. Am J Respir Crit Care Med 1999; 159: 1653-1659. (Pubitemid 29227883)
23. Faisal M, Hong Y, Liu J, et al. Fabrication of fluorescent silica nanoparticles hybridized with AIE luminogens and exploration of their applications as nanobiosensors in intracellular imaging. Chemistry 2010; 16: 4266-4272.
24. Yang H, Wu Q, Tang M, et al. In vitro study of silica nanoparticle-induced cytotoxicity based on real-time cell electronic sensing system. J Nanosci Nanotechnol 2010; 10: 561-568.
25. Mohammed KA, Nasreen N, Ward MJ, et al. Induction of acute pleural inflammation by Staphylococcus aureus. I. CD4+ T cells play a critical role in experimental empyema. J Infect Dis 2000; 181: 1693-1699. (Pubitemid 30387762)
26. Kachali C, Eltoum I, Horton D, et al. Use of mesothelin as a marker for mesothelial cells in cytologic specimens. Semin Diagn Pathol 2006; 23: 20-24. (Pubitemid 44415394)
27. Hagiwara SI, Ishii Y, Kitamura S. Aerosolized administration of N-acetylcysteine attenuates lung fibrosis induced by bleomycin in mice. Am J Respir Crit Care Med 2000; 162: 225-231. (Pubitemid 30469825)
28. Matsuoka H, Arai T, Mori M, et al. A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2002; 283: L103-L112. (Pubitemid 34764546)
29. Simler NR, Howell DC, Marshall RP, et al. The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats. Eur Respir J 2002; 19: 1124-1127. (Pubitemid 34649629)
30. Murakami S, Nagaya N, Itoh T, et al. Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301) attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2006; 290: L59-L65.
31. Murakami S, Nagaya N, Itoh T, et al. C-type natriuretic peptide attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2004; 287: L1172-L1177. (Pubitemid 39507194)
32. Izumo T, Kondo M, Nagai A. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice. Life Sci 2007; 80: 1882-1886. (Pubitemid 46560739)
33. Jantz MA, Antony VB. Pathophysiology of the pleura. Respiration 2008; 75: 121-133. (Pubitemid 351363863)
34. Lawson WE, Crossno PF, Polosukhin VV, et al. Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpes-virus infection. Am J Physiol Lung Cell Mol Physiol 2008; 294: L1119-L1126.
35. Lawson WE, Grant SW, Ambrosini V, et al. Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax 2004; 59: 977-980. (Pubitemid 39490784)
36. Kottmann RM, Hogan CM, Phipps RP, et al. Determinants of initiation and progression of idiopathic pulmonary fibrosis. Respirology 2009; 14: 917-933.
37. Brooks JS, LiVolsi VA, Pietra GG. Mesothelial cell inclusions in mediastinal lymph nodes mimicking metastatic carcinoma. Am J Clin Pathol 1990; 93: 741-748. (Pubitemid 20180932)
38. Argani P, Rosai J. Hyperplastic mesothelial cells in lymph nodes: report of six cases of a benign process that can stimulate metastatic involvement by mesothelioma or carcinoma. Hum Pathol 1998; 29: 339-346. (Pubitemid 28231897)
39. Alvarado Cabrero I, Sosa Romero A. Inclusiones epiteliales benignas en ganglios linfaticos pelvicos. Informe de does casos [Benign epithelial inclusions in pelvic lymph nodes. 2 case reports]. Ginecol Obstet Mex 2000; 68: 77-81.
40. Kir G, Eren S, Kir M. Hyperplastic mesothelial cells in pelvic and abdominal lymph node sinuses mimicking metastatic ovarian microinvasive serous borderline tumour. Eur J Gynaecol Oncol 2004; 25: 236-238. (Pubitemid 38268707)
41. Clement PB, Young RH, Oliva E, et al. Hyperplastic mesothelial cells within abdominal lymph nodes: mimic of metastatic ovarian carcinoma and serous borderline tumour - a report of two cases associated with ovarian neoplasms. Mod Pathol 1996; 9: 879-886. (Pubitemid 26319717)
42. Decologne N, Kolb M, Margetts PJ, et al. TGF-β1 induces progressive pleural scarring and subpleural fibrosis. J Immunol 2007; 179: 6043-6051.
43. Beattie J, Knox JF. Studies of mineral content and particle size distribution in the lungs of asbestos textile workers. In: Davis CN, ed. Inhaled Particles and Vapours. London, Pergamon Press, 1961; pp. 419-432.
44. Nagelschmidt G. Some observations of the dust content and composition in lungs with asbestosis, made during work on coal miners pneumoconiosis. Ann NY Acad Sci 1965; 132: 64-76.
45. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295-300.